10/07/2026
While reading so many comments, messages and posts coming from our partner PLHIV individuals and organizations about ARV stock outs and shortage it made me curious and my mind started on asking .......Why doesn't the Philippine government explore local manufacturing, technology transfer, or partnerships with domestic pharmaceutical companies to strengthen our medicine security and reduce our dependence on imported ARV's? I think this will be more effective if our government will diversify procurement sources to reduce the risk of stock-outs and should improve their procurement planning and their supply chain management or even the policies on procurement that affects distribution and availability of meds should be addressed. And hopefully our government must allow meaningful engagement of the PLHIV Community in procurement oversight and decision making to avoid these issues.
Recurring ARV stock-outs are not just procurement issues—they are failures that put the lives and health of people living with HIV at risk. Access to treatment is a fundamental human right, not a privilege.
To our partners, PLHIV communities, this is the moment to stand together. Let us raise our voices, let us demand accountability, and push for a health system that guarantees uninterrupted access to life-saving treatment.
ENOUGH FOR EXCUSES. ENOUGH on STOCK-OUTS. Every delayed delivery, every missed dose, and every treatment interruption puts lives at risk. WE DESERVE BETTER, and WE MUST DEMAND BETTER.